The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes.
 
Sarah E. Lochrin
Travel, Accommodations, Expenses - Novartis
 
Yelena Kemel
No Relationships to Disclose
 
Jessica Stuart
No Relationships to Disclose
 
James William Smithy
Research Funding - IO Biotech
 
Diana Mandelker
No Relationships to Disclose
 
Parisa Momtaz
No Relationships to Disclose
 
Walid Khaled Chatila
No Relationships to Disclose
 
Nikolaus Schultz
Honoraria - OneOncology
 
Michael A. Postow
Consulting or Advisory Role - Bristol-Myers Squibb; Cancer Expert Now; Chugai Pharma; Eisai; Erasca, Inc; Intellisphere; Merck; MJH Associates; Nektar; Novartis; Pfizer; WebMD
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Novartis (Inst); Rgenix (Inst)
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Genentech/Roche (I); Neurogene (I); Novartis (I); Optos (I); Outlook Therapeutics (I); Regeneron (I)
Patents, Royalties, Other Intellectual Property - Intellectual property rights (SOPHiA Genetics) (Inst)
Other Relationship - JCO Precision Oncology, Associate Editor; UpToDate, Section Editor
 
Alexander Noor Shoushtari
Consulting or Advisory Role - Bristol-Myers Squibb; Erasca, Inc; Novartis
Research Funding - Alkermes (Inst); Bristol-Myers Squibb; Checkmate Pharmaceuticals (Inst); Foghorn Therapeutics (Inst); Immunocore; Iovance Biotherapeutics (Inst); Linnaeus Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Targovax (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate